High Rate of Subsequent Cancers in Merkel Cell Carcinoma High Rate of Subsequent Cancers in Merkel Cell Carcinoma
In this cohort study, researchers identified 6146 patients from 17 registries of the SEER Program who had been diagnosed with a first primary cutaneous Merkel cell carcinoma between 2000 and 2018.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 14, 2023 Category: Cancer & Oncology Tags: Dermatology News Source Type: news
What to Know About Merkel Cell Carcinoma, the Rare Cancer that Killed Jimmy Buffett
(MedPage Today) -- Welcome to Culture Clinic, MedPage Today's collaboration with Northwell Health to offer a healthcare professional's take on the latest viral medical topics.
"Margaritaville" singer Jimmy Buffett died of Merkel cell carcinoma... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 6, 2023 Category: Dermatology Source Type: news
What to Know About the Rare Cancer That Killed Jimmy Buffett
The passing of popular singer and song writer Jimmy Buffett, who died Friday at age 76 from Merkel cell carcinoma, has thrust this form of skin cancer into the spotlight. But what exactly is it? (Source: WebMD Health)
Source: WebMD Health - September 6, 2023 Category: Consumer Health News Source Type: news
What is Merkel cell carcinoma? This rare form of skin cancer killed Jimmy Buffett after a 4-year battle
Jimmy Buffett died after a four-year battle with Merkel cell carcinoma. DM.com answers questions about it --what it is, how it wreaks havoc on the body, and what causes it. (Source: the Mail online | Health)
Source: the Mail online | Health - September 4, 2023 Category: Consumer Health News Source Type: news
Jimmy Buffett died after a 4-year fight with a rare skin cancer
SAG HARBOR, N.Y. — Jimmy Buffett, whose sun-drenched songs celebrated life by the shore, died of a rare, aggressive skin cancer, according to a statement on his website. Buffett, 76, had Merkel cell cancer, according to the statement, which was posted after initial news of his death emerged…#sagharbor #ny #jimmybuffett #margaritaville #hamptons #rhodeisland #mayoclinic #paradise (Source: Reuters: Health)
Source: Reuters: Health - September 4, 2023 Category: Consumer Health News Source Type: news
Merkel Cell Carcinoma: What To Know About The Skin Cancer That Killed Jimmy Buffett
Vacation extraordinaire and topical rockstar Jimmy Buffett died Friday night from an aggressive form of skin cancer called Merkel cell carcinoma, a rare disease that impacts only one in 130,000 Americans each year and is often caused by exposure to the sun. Buffett, 76, had been fighting Merkel…#jimmybuffett #longisland #baptisthealth #margaritaville #big8 #kneedeep #zacbrown #rhodeisland #brigham #boston (Source: Reuters: Health)
Source: Reuters: Health - September 3, 2023 Category: Consumer Health News Source Type: news
Incyte gets FDA approval for new drug to treat rare form of skin cancer
Incyte's newly approved drug targets advanced Merkel cell carcinoma, a condition that afflicts fewer than one out of 100,00 people. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - March 23, 2023 Category: Health Management Authors: John George Source Type: news
High Early Recurrence Rates With Merkel Cell Carcinoma High Early Recurrence Rates With Merkel Cell Carcinoma
The overall 5-year recurrence rate of this rare, aggressive skin cancer was 40% in a prospective cohort study.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - March 3, 2022 Category: Internal Medicine Tags: Dermatology News Source Type: news
Skin Cancer App Fails to Identify Rare, Aggressive Cancers
Sensitivity and specificity for detecting Merkel cell carcinoma and amelanotic melanoma was 79.4 and 37.7 percent, respectively (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 14, 2021 Category: Cancer & Oncology Tags: Dermatology, Family Medicine, Internal Medicine, Oncology, Pathology, Conference News, Source Type: news
Mohs Surgery Favorable as Monotherapy for Early Merkel Cell Mohs Surgery Favorable as Monotherapy for Early Merkel Cell
The findings add to a growing body of literature supporting Mohs for many types of rare tumors.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 2, 2021 Category: Consumer Health News Tags: Dermatology News Source Type: news
Oncotarget: Predictors of immunotherapy benefit in Merkel cell carcinoma
(Impact Journals LLC) Dr. Glenn J. Hanna from CCR/NCI in Bethesda, MD as well as The Dana-Farber Cancer Institute in Boston Massachusetts said, " Merkel cell carcinoma (MCC) is a relatively rare cancer, with roughly 400 cases per 100,000 persons each year in the United States " . (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 22, 2021 Category: International Medicine & Public Health Source Type: news
Immunotherapy Should Be First Line in Merkel Cell Carcinoma Immunotherapy Should Be First Line in Merkel Cell Carcinoma
Pembrolizumab demonstrated durable tumor control, a generally manageable safety profile, and favorable survival outcomes compared with historical data in advanced MCC.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 18, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Tumor Control Durable With Pembrolizumab in Merkel Cell Cancer
28 of 50 advanced MCC patients responded; 24 - month overall survival rate was 68.7 percent (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 27, 2019 Category: Cancer & Oncology Tags: Dermatology, Oncology, Pharmacy, Journal, Source Type: news
Tumor Control Durable With Pembrolizumab in Merkel Cell Cancer
WEDNESDAY, Feb. 27, 2019 -- For patients with advanced Merkel cell carcinoma (aMCC), pembrolizumab is associated with durable tumor control and favorable overall survival, according to a study published online Feb. 7 in the Journal of Clinical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 27, 2019 Category: Pharmaceuticals Source Type: news
Immunotherapy appears better than chemotherapy for aggressive type of skin cancer
(Johns Hopkins Medicine) The first study of the immunotherapy drug pembrolizumab as the initial treatment for patients with a rare but aggressive form of skin cancer known as Merkel cell carcinoma reports better responses and longer survival than expected with conventional chemotherapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 7, 2019 Category: International Medicine & Public Health Source Type: news
